top of page

 Pioneering Non-Invasive   Solutions for Neurological   Disease Management 

 Blinkcns utilizes the blink reflex using its FDA-cleared  EyeStat   device—a 30-second, non-invasive test that delivers faster,   objective data for neurological assessment and disease   management, empowering earlier detection, personalized   care, and improved patient care and outcomes.  

A Game-Changer in Neurology

Introducing EyeStat5, the next generation of the world's first FDA-cleared technology indicated to measure and assess the blink reflex.

*EyeStat5 is pending FDA clearance

Screenshot 2024-11-09 at 4.28.37 PM.png
Blink_2300717.148.png
Blink_2300717_edited.png
Blink_2300717_edited.png
Screenshot 2024-11-09 at 6.28.35 PM.png
Blinktbi_EyeStat_5_Blues.png

Blinkcns has expanded its technology and will be used both in a clinical and telehealth (e.g., athletic facility or in-home) setting. Our i-blink app for clinicians and patients will be available on iPhone and Android mobile devices. This innovation enables low-cost and objective capturing of spontaneous and stimulated blinking for enhanced neurological management.

Screenshot 2024-11-09 at 3.58.19 PM.png
Screenshot 2024-11-09 at 6.28.35 PM.png

Our Clinical and Research Partners 

MUSC-logo-1.png-1.webp
Grey minimalist business project presentation .png
Grey minimalist business project presentation  (1).png
upen.png
tmp_4071_5-17-2024_102608_.png
Screenshot 2024-11-09 at 6.28.35 PM.png

Stay in the Loop

Keep abreast of the latest trends and breakthroughs in neurological science through our news articles, upcoming events, and press releases.

bottom of page